Locomotor Training for Stroke
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the High-Intensity Locomotor Training Program treatment for stroke?
Is high-intensity locomotor training safe for humans?
The studies reviewed do not provide specific safety data for high-intensity locomotor training, but they do suggest that it is being actively researched and used in clinical settings for stroke rehabilitation, indicating a level of acceptance in the medical community. However, the relative benefits and risks compared to moderate-intensity training are not well understood, so it's important to consult with healthcare providers for personalized advice.12678
How does the High-Intensity Locomotor Training Program treatment differ from other treatments for stroke?
The High-Intensity Locomotor Training Program is unique because it focuses on high-intensity exercise, which means working at a level that significantly raises the heart rate. This approach is thought to improve walking ability more effectively by targeting specific movement deficits and enhancing the function of the affected limb, compared to lower-intensity or less targeted therapies.13579
What is the purpose of this trial?
The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery.This is a randomized controlled trial conducted at a single IR facility. Investigators will randomize patients to receive one of two distinct HIGT interventions or a high step count intervention during standard care.
Research Team
Susan Camillieri
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for stroke patients in the early recovery phase who are currently undergoing inpatient rehabilitation. Participants should be able to handle a certain level of physical activity but specifics on inclusion and exclusion criteria were not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of three distinct locomotor training protocols for 10 consecutive 1-hour sessions over a 10-day period
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- High-Intensity Locomotor Training Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institutes of Health (NIH)
Collaborator